GPhA Commends Launch of Bipartisan Affordable Medicines Caucus

Published Online: Friday, May 2, 2014
Follow Pharmacy_Times:
PRESS RELEASE

WASHINGTON, DC (May 2, 2014) — The Generic Pharmaceutical Association (GPhA) applauds the launch of the bipartisan Affordable Medicines Caucus, co-chaired by Representative Peter Welch (D-VT) and Representative Keith Rothfus (R-PA). GPhA and its members look forward to working with the Caucus to support its mission to educate patients and policymakers on the critical role of affordable generic medicines in holding down health costs.

“Members of both parties agree: taking full advantage of generic medicines is a common sense way to save billions of dollars for the government, and for millions of Americans.” said Ralph G. Neas, President and CEO of the Generic Pharmaceutical Association. “Indeed, an IMS health analysis released by GPhA in December 2013 showed that generic pharmaceuticals have achieved $1.2 trillion in savings over the past decade, nearly $217 billion in 2012 alone, all of which translates to more than one billion dollars in savings every other day.”

The Caucus will share the newest information on the positive impact of generics on cost savings and help legislators track the latest developments in the field. Armed with this knowledge, lawmakers can make informed decisions about the future of healthcare policy.

“Working together,” said Neas, “we can build on the tremendous 30-year track record of bipartisan cooperation that has resulted in unprecedented access to safe, affordable, and life-changing generic medicines in America and around the world.”

Related Articles
Today, an expert panel at the 2015 Generic Pharmaceutical Association Annual Meeting, “FDA and Industry Perspectives on Quality Culture,” convened to discuss a shared commitment with industry to the highest standards of manufacturing quality and regulatory processes.
The Generic Pharmaceutical Association today announced the election of its 2015 Executive Committee and Board of Directors.
The Generic Pharmaceutical Association and its members applaud the significant progress made by the agency during Commissioner of Food and Drugs Dr. Margaret Hamburg’s six years leading the U.S. Food and Drug Administration. Throughout her tenure, Dr. Hamburg has been a tireless advocate for patient safety and a leader in efforts to assure that FDA decisions are guided by scientific principles.
“The Generic Pharmaceutical Association (GPhA) is deeply disappointed in today’s 21st Century Cures discussion draft. While we appreciate that it is a draft, in its current form, the bill would upset the important balance between creating competition and encouraging innovation in the pharmaceutical marketplace, putting savings at risk and limiting access to affordable medicines for millions of American patients.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$